APA
Evans S. R., Schwartz A. M., Shchepotin E. I., Uskokovic M. & Shchepotin I. B. (19990223). Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Evans S R, Schwartz A M, Shchepotin E I, Uskokovic M and Shchepotin I B. 19990223. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Evans S. R., Schwartz A. M., Shchepotin E. I., Uskokovic M. and Shchepotin I. B. (19990223). Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Evans S R, Schwartz A M, Shchepotin E I, Uskokovic M and Shchepotin I B. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft. : Clinical cancer research : an official journal of the American Association for Cancer Research. 19990223.